DSIJ Mindshare

The company’s revenue for the quarter remained flat at Rs. 835.5 crore as compared to Rs. 834.2 crore in the preceding quarter. Revenue mix by segment, services (43 per cent of total revenue), digital (22 per cent), alliance (29.5 per cent) and Accelerite (5.5 per cent).

Aleor Dermaceuticals Ltd, a joint venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies has cleared its first USFDA inspection.

Overall volumes in futures & options currently stand at 98.34 lakh contracts with a turnover of Rs. 8,17,144.32 crore.

Overall volumes in futures & options currently stand at 98.34 lakh contracts with a turnover of Rs. 8,17,144.32 crore.

The company has bagged a purchase order of Rs. 111 crore for supply of country-wide next generation digital network for the Indian Navy's communication grid.